Re: Long-Term Safety, Tolerability and Efficacy of Flexible-Dose Fesoterodine in Elderly Patients with Overactive Bladder: Open-Label Extension of the SOFIA Trial Editorial Comment

被引：0
|
作者：
Griebling, Tomas L.
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 192卷 / 06期
关键词：
D O I：
10.1016/j.juro.2014.09.064
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1766 / 1766
页数：1
相关论文
共 50 条
  • [1] Long-Term Safety, Tolerability and Efficacy of Flexible-Dose Fesoterodine in Elderly Patients With Overactive Bladder: Open-Label Extension of the SOFIA Trial
    Wagg, Adrian
    Khullar, Vik
    Michel, Martin C.
    Oelke, Matthias
    Darekar, Amanda
    Bitoun, Caty Ebel
    [J]. NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 106 - 114
  • [2] Long-Term Safety, Tolerability and Efficacy of Fesoterodine in Subjects with Overactive Bladder Symptoms Stratified by AgePooled Analysis of Two Open-Label Extension Studies
    Peter K. Sand
    John Heesakkers
    Stephen R. Kraus
    Martin Carlsson
    Zhonghong Guan
    Sandra Berriman
    [J]. Drugs & Aging, 2012, 29 : 119 - 131
  • [3] Long-Term Safety, Tolerability and Efficacy of Fesoterodine in Subjects with Overactive Bladder Symptoms Stratified by Age Pooled Analysis of Two Open-Label Extension Studies
    Sand, Peter K.
    Heesakkers, John
    Kraus, Stephen R.
    Carlsson, Martin
    Guan, Zhonghong
    Berriman, Sandra
    [J]. DRUGS & AGING, 2012, 29 (02) : 119 - 131
  • [4] Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study
    Wyndaele, J. -J.
    Goldfischer, E. R.
    Morrow, J. D.
    Gong, J.
    Tseng, L. -J.
    Guan, Z.
    Choo, M. -S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 560 - 567
  • [5] Patient-Optimized Doses of Fesoterodine Improve Bladder Symptoms in an Open-Label, Flexible-Dose Study Editorial Comment
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (03): : 994 - 995
  • [6] Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial
    McConville, B
    Carrero, L
    Sweitzer, D
    Potter, L
    Chaney, R
    Foster, K
    Sorter, M
    Friedman, L
    Browne, K
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 75 - 82
  • [7] Long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder symptoms
    Van Kerrebroeck, P. E. V.
    Heesakkers, J.
    Berriman, S.
    Aiyer, L. Padmanabhan
    Carlsson, M.
    Guan, Z.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 584 - 593
  • [8] Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms
    Scarpero, Harriette
    Sand, Peter K.
    Kelleher, Con J.
    Berriman, Sandra
    Bavendam, Tamara
    Carlsson, Martin
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 921 - 930
  • [9] Re: Efficacy and Safety of Fesoterodine Treatment for Overactive Bladder Symptoms in Elderly Women with and without Hypertension Editorial Comment
    Griebling, Tomas L.
    [J]. JOURNAL OF UROLOGY, 2019, 201 (03): : 420 - 421
  • [10] Efficacy, tolerability and safety of long-term darifenacin treatment in older patients with overactive bladder: Analysis of results from a 2-year, open-label extension study
    Dwyer, P.
    Lheritier, K.
    Steel, M.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2006, 25 (06) : 657 - 658
12345